Rogerio C. Lilenbaum, MD

CCOP - Mount Sinai Medical ...Miami Beach, Florida - 33140 (305-535-3310) Mount Sinai Comprehensive Cancer CenterMiami Beach, Florida - 33140 |
- CLINICAL TRIALS 14
- CONDITIONS21
- INTERVENTIONS40
- SINCE1984

Zoledronic Acid in Treating Patients With Metastatic Breast Cancer Metastatic Prostate Cancer or Multiple Myeloma With Bone Involvement
March 2009 - May 2015

Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
May 2009 - December 2012

Bevacizumab and Paclitaxel Paclitaxel Albumin-Stabilized Nanoparticle Formulation or Ixabepilone in Treating Patients With Stage IIIC or Stage IV Breast Cancer
October 2008 - October 2010

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
March 2008 - October 2008

Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
March 2008 - May 2012

Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
June 2003 - April 2011

Genetic Study of Patients With Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Myelodysplastic Syndromes or Multiple Myeloma
June 1984 - July 2005

Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer
November 2007 - November 2013

Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I Stage II or Stage III Non-Small Cell Lung Cancer
October 2005 - February 2008

Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
July 2006 - April 2024

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
November 2005 - June 2008

Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
April 2008 - August 2010

L-Arginine Supplements in Treating Women Who Are Cancer Survivors
May 2007 - May 2010

Trial of Poor Performance Status Patients (ToPPS)
May 2009 - December 2011
Breast Neoplasms
Colonic Neoplasms
Lung Neoplasms
Adenocarcinoma
Prostatic Neoplasms
Multiple Myeloma
Neoplasms, Plasma Cell
Leukemia
Leukemia, Lymphoid
Neoplasms
Neoplasm Metastasis
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Leukemia, Myeloid, Acute
Leukemia, Myeloid
Myelodysplastic Syndromes
Preleukemia
Carcinoma, Non-Small-Cell Lung
Carcinoma, Small Cell
Infertility
Myeloproliferative Disorders
Colorectal Neoplasms
Placebo
Intensity-Modulated Radiation Therapy
Immunohistochemistry Staining Method
Laboratory Biomarker Analysis
Zoledronic Acid
Study Of Socioeconomic And Demographic Variables
Paclitaxel
Carboplatin
Bevacizumab
Docetaxel
Fluorouracil
Leucovorin Calcium
Erlotinib Hydrochloride
Gene Expression Analysis
Polymorphism Analysis
Cyclophosphamide
Radiation Therapy
Pemetrexed Disodium
3-Dimensional Conformal Radiation Therapy
Oxaliplatin
Doxorubicin Hydrochloride
Polymerase Chain Reaction
Sunitinib Malate
Mutation Analysis
Cetuximab
Study Of High Risk Factors
Matrix-Assisted Laser Desorption/Ionization Time Of Flight Mass Spectrometry
Irinotecan Hydrochloride
Pemetrexed
Ixabepilone
Paclitaxel Albumin-Stabilized Nanoparticle Formulation
Ac Regimen
Cytogenetic Analysis
Iodine I 125
Palladium Pd 103
Chromosomal Translocation Analysis
Chromogenic In Situ Hybridization
Fluorescent Antibody Technique
Antiandrogen Therapy
L-Arginine/Korean Ginseng/ Gingko Biloba/Damiana-Based Supplement



